Home

sekera zpívat Elektropozitivní roma index tumor marker kanál životopis kulka

Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of  Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as  Diagnostic Tests in Ovarian Cancer | International Journal of Cancer
Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer | International Journal of Cancer

Human Epididymis Protein 4 - an overview | ScienceDirect Topics
Human Epididymis Protein 4 - an overview | ScienceDirect Topics

SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy  algorithm (ROMA), and risk malignancy index (RMI) for the classification of  ovarian masses A comparison of CA125, HE4, risk ovarian
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian

Diagnostic measures comparison for ovarian malignancy risk in Epithelial  ovarian cancer patients: a meta-analysis | Scientific Reports
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports

Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for  Preoperative Assessment of Adnexal Tumors
Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors

HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125  Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete  Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis
HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis

Diagnostic Values of HE4, CA125, RMI and ROMA using Standard and... |  Download Table
Diagnostic Values of HE4, CA125, RMI and ROMA using Standard and... | Download Table

JGO :: Journal of Gynecologic Oncology
JGO :: Journal of Gynecologic Oncology

PDF] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian  cancer | Semantic Scholar
PDF] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar

Diagnostic measures comparison for ovarian malignancy risk in Epithelial  ovarian cancer patients: a meta-analysis | Scientific Reports
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports

ROMA (Risk of Ovarian Malignancy Algorithm)
ROMA (Risk of Ovarian Malignancy Algorithm)

RMI and ROMA are equally effective in discriminating between benign and  malignant gynecological tumors: A prospective population‐based study -  Liest - 2019 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online  Library
RMI and ROMA are equally effective in discriminating between benign and malignant gynecological tumors: A prospective population‐based study - Liest - 2019 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online Library

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian  Cancer: A Guide for the Radiologist | RadioGraphics
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics

Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic  Performance Than HE4 and CA125 in the Presurgical Differentiation of  Adnexal Tumors in Polish Women?
Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?

He4 and Risk for Ovarian Cancer Algorithm - Dr Lal PathLabs
He4 and Risk for Ovarian Cancer Algorithm - Dr Lal PathLabs

Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and  risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models  with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms

Serum CA125, HE4 and ROMA levels according to histology, FIGO stage and...  | Download Table
Serum CA125, HE4 and ROMA levels according to histology, FIGO stage and... | Download Table

Specific forest map for diagnosis of ovarian cancer with the ROMA index...  | Download Scientific Diagram
Specific forest map for diagnosis of ovarian cancer with the ROMA index... | Download Scientific Diagram

differences between HE4, CA125, and ROMA values and sensitivity, PPV,... |  Download Scientific Diagram
differences between HE4, CA125, and ROMA values and sensitivity, PPV,... | Download Scientific Diagram

Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis.  - Document - Gale Academic OneFile
Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis. - Document - Gale Academic OneFile

Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and  risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models  with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms

Correlations between IOTA index, CA125, HE4, ROMA index | Download  Scientific Diagram
Correlations between IOTA index, CA125, HE4, ROMA index | Download Scientific Diagram

SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy  algorithm (ROMA), and risk malignancy index (RMI) for the classification of  ovarian masses A comparison of CA125, HE4, risk ovarian
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian

CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline  Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages
CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages

Diagnostics | Free Full-Text | The Comparison of Three Predictive Indexes  to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma:  The Characteristics and Efficacy
Diagnostics | Free Full-Text | The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy

Analysis of falsely elevated risk of ovarian malignancy algorithm in women  with ovarian endometrioma
Analysis of falsely elevated risk of ovarian malignancy algorithm in women with ovarian endometrioma

PDF] A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA),  and risk malignancy index (RMI) for the classification of ovarian masses |  Semantic Scholar
PDF] A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Semantic Scholar